Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Aduro Biotech Announces Phase 2 Clinical Trial Results for Pancreatic Cancer Combination Immunotherapy Published in Journal of Clinical Oncology

Business Wire January 12, 2015

Nabsys and Ariana Pharma Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers

Business Wire January 12, 2015

Illumina Expands World's Most Comprehensive Next-Generation Sequencing Portfolio

Business Wire January 12, 2015

CLT Joules Selects Startups for 2015 Energy Accelerator

PR Newswire January 12, 2015

Revisions to Molecular Testing Guidelines Continues to Give Hope to Lung Cancer Patients

Business Wire January 12, 2015

Eisai Aghast at NHS England Decision to Remove Life Extending Breast Cancer Treatment From Cancer Drugs Fund

PR Newswire January 12, 2015

TRADE NEWS: Agilent Technologies Introduces Microarray for Rapid Screening of Aneuploidy in Single Cells from Embryos

Business Wire January 12, 2015

Capricor Therapeutics Initiates the DYNAMIC Clinical Trial for the Treatment of Advanced Heart Failure

GlobeNewswire January 12, 2015

Capricor Therapeutics Initiates the DYNAMIC Clinical Trial for the Treatment of Advanced Heart Failure

GlobeNewswire January 12, 2015

Clinical Microbiology Market Worth $12,411.36 Million in 2019

PR Newswire January 12, 2015

RetroSense Therapeutics to Present at 7th Annual Biotech Showcase Conference

Business Wire January 12, 2015

Cure Duchenne Ventures LLC To Provide $1 Million to Capricor Therapeutics to Advance Promising Research to Treat Heart Disease Associated with Duchenne Muscular Dystrophy

Business Wire January 12, 2015

CORRECTING and REPLACING -- TESARO Announces Expansion of Niraparib Clinical Program and Outlines Late-Stage Program Milestones for 2015

GlobeNewswire January 12, 2015

ETST Announces New Trademarks and Is Working to File New Patents; ETST Prepares to Release Several New Scientifically Advanced CBD (Cannabidiol) Rich Hemp Oil Formulations and Flavors Plus Has Added New International Partner

Marketwired January 12, 2015

ArcherDX Launches from QIAGEN Acquisition of Enzymatics

Business Wire January 12, 2015

Helmsley Charitable Trust Makes Grants Totaling $6.4 Million to Sage Bionetworks, the Hypothes.is Project and the Mozilla Foundation

GlobeNewswire January 12, 2015

Protea Launches New Tissue Analytics Software and Workflow

GlobeNewswire January 12, 2015

Research and Markets: Emerging Trends in Cell Banking (Technical Insights)

Business Wire January 12, 2015

Celgene Corporation Announces 2015 and Long-Term Financial Outlook and Preliminary 2014 Results

Business Wire January 12, 2015

Cornerstone Pharmaceuticals Initiates Phase I Clinical Trial of CPI-613 for the Treatment of Metastatic Colorectal Cancer

GlobeNewswire January 12, 2015